Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation
Laboratory Animal Research · 2018 · 34 (1) · 1
DOI: 10.5625/lar.2018.34.1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Animal Research, 2018. Verfasst von Soon-Young Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Dongshin University, Naju, Korea. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Ministry of Food and Drug Safety.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Dongshin University, Naju, Korea.
- Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan, Korea.
- College of Veterinary Medicine, Chonnam National University, Gwangju, Korea.
- Department of Physical Therapy, Dongshin University, Naju, Korea.
Förderung
- Ministry of Food and Drug Safety
Zitieren
APA
Lee, S. Y., Cho, J. H., Cho, S. S., Bae, C. S., Kim, G. Y., & Park, D. H. (2018). Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation. Laboratory Animal Research, 34(1), 1. https://doi.org/10.5625/lar.2018.34.1.1
Vancouver
Lee SY, Cho JH, Cho SS, Bae CS, Kim GY, Park DH. Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation. Laboratory Animal Research. 2018;34(1):1. doi:10.5625/lar.2018.34.1.1
BibTeX
@article{Lee2018,
author = {Lee, Soon-Young and Cho, Jin-Ho and Cho, Seung Sik and Bae, Chun-Sik and Kim, Gye-Yeop and Park, Dae-Hun},
title = {Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation},
journal = {Laboratory Animal Research},
year = {2018},
volume = {34},
number = {1},
pages = {1},
doi = {10.5625/lar.2018.34.1.1}
}
EUVIMED